Details for Patent: 9,012,469
✉ Email this page to a colleague
Which drugs does patent 9,012,469 protect, and when does it expire?
Patent 9,012,469 protects MOVANTIK and is included in one NDA.
This patent has forty-five patent family members in thirty-eight countries.
Summary for Patent: 9,012,469
| Title: | Crystalline naloxol-peg conjugate |
| Abstract: | Naloxol-polyethlyene glycol conjugates of the formula: are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided. |
| Inventor(s): | .ANG.slund; Bengt Leonard (Alderley Park, GB), Aurell; Carl-Johan (Alderley Park, GB), Bohlin; Martin Hans (Alderley Park, GB), Healy; Eric Thomas (Waltham, MA), Jensen; David Richard (Waltham, MA), Jonaitis; David Thomas (Waltham, MA), Parent; Stephan (Waltham, MA), Sebhatu; Tesfai (Alderley Park, GB), Ymen; Bo Ingvar (Alderley Park, GB) |
| Assignee: | AstraZeneca AB (Sodertalje, SE) Nektar Therapeutics (San Francisco, CA) |
| Application Number: | 13/823,953 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,012,469 |
|
Patent Claim Types: see list of patent claims | Compound; Use; Formulation; Composition; Dosage form; |
Drugs Protected by US Patent 9,012,469
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-001 | Sep 16, 2014 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,012,469
| PCT Information | |||
| PCT Filed | September 29, 2011 | PCT Application Number: | PCT/SE2011/051161 |
| PCT Publication Date: | April 05, 2012 | PCT Publication Number: | WO2012/044243 |
International Family Members for US Patent 9,012,469
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 083268 | ⤷ Try a Trial | |||
| Australia | 2011307608 | ⤷ Try a Trial | |||
| Brazil | 112013007113 | ⤷ Try a Trial | |||
| Canada | 2812649 | ⤷ Try a Trial | |||
| Chile | 2013000866 | ⤷ Try a Trial | |||
| China | 103237547 | ⤷ Try a Trial | |||
| Colombia | 6700851 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
